Estrella Immunopharma, Inc. (ESLA)

CIK 0001844417 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 —
FY-2025
Latest FY-2025 —
Q3-2025 —
Q2-2025 —
Q1-2025 —
FY-2024
Q1-2025 —
FY-2024
FY-2024 —
Q3-2024 —
Q2-2023 —
Q2-2023 —
FY-2022 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Document and Entity Information
—
Audit Information
—
Statements
Balance Sheets
—
Unaudited Condensed Balance Sheets
—
Unaudited Condensed Consolidated Balance Sheets
—
Balance Sheets (P)
—
Consolidated Balance Sheets
Unaudited Condensed Balance Sheets (P)
—
Unaudited Condensed Consolidated Balance Sheets (P)
—
Consolidated Balance Sheets (P)
Statements of Operations
—
Unaudited Condensed Consolidated Statements of Operations
—
Unaudited Condensed Statements of Operations
—
Consolidated Statements of Changes In Stockholders (deficit) Equity (unaudited)
—
Consolidated Statements of Changes In Stockholders Deficit
—
Consolidated Statements of Operations
Statements of Changes In Stockholders' Deficit
—
Unaudited Condensed Consolidated Statements of Changes In Stockholders (deficit) Equity
—
Unaudited Condensed Consolidated Statements of Operations (P)
—
Unaudited Condensed Statements of Changes In Stockholders Equity
—
Consolidated Statements of Operations (P)
Statements of Cash Flows
—
Unaudited Condensed Consolidated Statements of Changes In Stockholders Equity (deficit)
—
Unaudited Condensed Statements of Cash Flows
—
Condensed Consolidated Statements of Changes In Stockholders Equity
—
Consolidated Statements of Changes In Stockholders Equity (deficit)
—
Unaudited Condensed Consolidated Statements of Cash Flows
—
Consolidated Statements of Cash Flows
Notes
Cash Held In Trust Account
Collaboration Agreement
—
Commitments & Contingencies
Commitments and Contingencies
Cybersecurity Risk Management and Strategy Disclosure
—
Deferred Underwriters' Business Combination Fees
Extension Note Receivable
Income Taxes
Initial Public Offering
Insider Trading Arrangements
Investments Held In Trust Account
Leases
Organization and Business Operation
Other Payables and Accrued Liabilities
Pay Vs Performance Disclosure
Preferred Stock
Private Placement
Promissory Note
Related Party Transactions
Reverse Recapitalization
Segment Information
Significant Accounting Policies
Stock Based Compensation
Stock Redemption Payable
Stock-based Compensation
—
Stockholders (deficit) Equity
Stockholders Equity (deficit)
Stockholders' Deficit
Subsequent Events
Transition Period Comparative Data
—